Lets all not forget:
U.S. Department of Health
and Human Services (HHS) has awarded up to an estimated US$231 million contract
to its wholly owned subsidiary, Biota Scientific Management Pty Ltd, for the advanced
development of laninamivir. The contract is fully funded over an estimated five (5)
year period and is contingent upon the delivery of key milestones throughout the period.
